Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

  1. Gianni, L.
  2. Eiermann, W.
  3. Semiglazov, V.
  4. Manikhas, A.
  5. Lluch, A.
  6. Tjulandin, S.
  7. Zambetti, M.
  8. Vazquez, F.
  9. Byakhow, M.
  10. Lichinitser, M.
  11. Climent, M.A.
  12. Ciruelos, E.
  13. Ojeda, B.
  14. Mansutti, M.
  15. Bozhok, A.
  16. Baronio, R.
  17. Feyereislova, A.
  18. Barton, C.
  19. Valagussa, P.
  20. Baselga, J.
Journal:
The Lancet

ISSN: 0140-6736

Year of publication: 2010

Volume: 375

Issue: 9712

Pages: 377-384

Type: Article

DOI: 10.1016/S0140-6736(09)61964-4 GOOGLE SCHOLAR